Get the Stockscreener App
2.96
5.71%
0.16
After Hours:
3.04
0.08
+2.70%
Abvc Biopharma Inc stock is traded at $2.96, with a volume of 114.33K.
It is up +5.71% in the last 24 hours and down -1.33% over the past month.
ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. Its drug products focus on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.
See More
Previous Close:
$2.80
Open:
$2.8
24h Volume:
114.33K
Relative Volume:
1.04
Market Cap:
$69.68M
Revenue:
$152.40K
Net Income/Loss:
$-10.52M
P/E Ratio:
-1.1873
EPS:
-2.4931
Net Cash Flow:
$-4.26M
1W Performance:
+2.42%
1M Performance:
-1.33%
6M Performance:
+181.90%
1Y Performance:
+348.48%
1-Day Range:
$2.80
$3.02
1-Week Range:
$2.75
$3.02
52-Week Range:
$0.40
$5.48
Abvc Biopharma Inc Stock (ABVC) Company Profile
Name
Abvc Biopharma Inc
Sector
Industry
Phone
510-668-0881
Address
44370 OLD WARM SPRINGS BLVD., FREMONT
Compare ABVC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ABVC
Abvc Biopharma Inc
|
2.96 | 65.92M | 152.40K | -10.52M | -4.26M | -2.4931 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Abvc Biopharma Inc Stock (ABVC) Latest News
Will ABVC BioPharma Inc. stock sustain high P E ratiosSell Signal & Daily Growth Stock Tips - newser.com
ABVC BioPharma Reports 230% YoY Licensing Revenue Growth and 181% Asset Expansion in Q3 2025 - NewMediaWire
Will ABVC BioPharma Inc. price bounce be sustainableWeekly Earnings Recap & Safe Entry Point Identification - newser.com
Market reaction to ABVC BioPharma Inc.’s recent newsEarnings Overview Summary & Momentum Based Trading Signals - newser.com
How geopolitical tensions affect ABVC BioPharma Inc. stock2025 Retail Activity & Low Drawdown Investment Strategies - newser.com
How ABVC BioPharma Inc. stock benefits from strong dollarMarket Growth Summary & Reliable Breakout Stock Forecasts - newser.com
Building trade automation scripts for ABVC BioPharma Inc.July 2025 Movers & Safe Capital Growth Trade Ideas - newser.com
ABVC BIOPHARMA, INC. SEC 10-Q Report - TradingView
Automated trading signals detected on ABVC BioPharma Inc.2025 Market Overview & Safe Entry Momentum Stock Tips - newser.com
Why analysts upgrade ABVC BioPharma Inc. stockWall Street Watch & Free Daily Entry Point Trade Alerts - newser.com
Is ABVC BioPharma Inc. stock a buy before product launchesQuarterly Risk Review & Technical Entry and Exit Tips - newser.com
How ABVC BioPharma Inc. stock trades before earningsPortfolio Performance Report & High Return Trade Guides - newser.com
Forecasting ABVC BioPharma Inc. price range with options dataJuly 2025 Market Mood & High Yield Stock Recommendations - newser.com
Key resistance and support levels for ABVC BioPharma Inc.Weekly Profit Report & Reliable Volume Spike Trade Alerts - newser.com
How ABVC BioPharma Inc. stock performs after earningsWeekly Trade Recap & Real-Time Stock Movement Alerts - newser.com
Will a bounce in ABVC BioPharma Inc. offer an exitMarket Movement Recap & Stepwise Trade Signal Implementation - newser.com
Published on: 2025-11-02 05:07:12 - newser.com
How institutional ownership impacts ABVC BioPharma Inc. stockMarket Weekly Review & Expert Curated Trade Ideas - newser.com
Will earnings trigger a reversal in ABVC BioPharma Inc.July 2025 Short Interest & Weekly High Conviction Trade Ideas - newser.com
ABVC BioPharma, Inc. (NASDAQ:ABVC) Short Interest Update - MarketBeat
Can ABVC BioPharma Inc. rally from current levels2025 Year in Review & Low Drawdown Momentum Ideas - newser.com
How resilient is ABVC BioPharma Inc. stock in market downturnsMarket Activity Summary & Real-Time Stock Price Movement Reports - newser.com
Is Buying Stock In ABVC BioPharma Inc (ABVC) A Good Move Today? - fostersleader.com
ABVC BioPharma Receives $100,000 Licensing Payment from OncoX BioPharma, Advancing Oncology Partnership Strategy - citybuzz -
ABVC BioPharma Receives Additional US$100,000 Licensing Payment from OncoX BioPharma, Bringing Total Payments to US$695,950 - NewMediaWire
Is ABVC BioPharma Inc. stock cheap at current valuationDollar Strength & Weekly Top Performers Watchlists - newser.com
ABVC BioPharma board approves performance incentive plan tied to $1B market cap - Investing.com Nigeria
ABVC BioPharma Inc Stock Analysis and ForecastVolume Weighted Average Price & Budget Friendly Stock Tips - earlytimes.in
ABVC sets performance plan: activates at $1B market cap with caps - Stock Titan
Published on: 2025-10-30 06:48:04 - newser.com
Abvc Biopharma Inc Stock (ABVC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.64%
0.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):